60 Ml Denosumab Solution Injection

Name: 60 Ml Denosumab Solution Injection
Brand: NEETCO BIOPHARMA
Price: 6000 INR
Availability: InStock

Price 6000 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

60 Ml Denosumab Solution Injection Specification

Salt Composition
Denosumab 60 mg/ml

Indication
Treatment of osteoporosis, bone loss, and prevention of skeletal-related events in patients with bone metastases

Dosage Form
Solution for Injection

Enzyme Types
Monoclonal Antibody Not an enzyme

Feature
Ready-to-use prefilled syringe, convenient dosing, preservative-free

Ingredients
Denosumab, excipients, sterile water

Application
Subcutaneous injection

Ph Level
Neutral (around pH 6.0) - as per formulation standard

Temperature Needed For Fermentation
Not required (biotechnologically synthesized monoclonal antibody)

Physical Color/Texture
Clear to slightly opalescent, colorless liquid

Fermentation Smell
Odorless

Enzymatic Activity
Not applicable; works via immunologic pathway

Storage Instructions
Store between 2C and 8C. Do not freeze. Keep in original package.

Shelf Life
24 months from date of manufacture

Batch Number
Printed on label

Single Use/Multiple Use
Single use only

Patient Population
Adults only

Contraindications
Hypocalcemia, known hypersensitivity to denosumab

Brand Name
Generic or as per Manufacturer

Bar Code
Available on packaging

Registration Category
Rx-biological

Disposal Instructions
Dispose as per biomedical waste guidelines

Sterility
Sterile aqueous solution

Prescription Status
Prescription only

Route of Administration
Subcutaneous

Packaging Type
Pre-filled syringe, 60 ml

About 60 Ml Denosumab Solution Injection

Unlock top-rated treatment with the resplendent 60 ml Denosumab Solution Injection, a celebrated monoclonal antibody designed for subcutaneous administration. Available in a ready-to-use, rare prefilled syringe, this prescription-only, sterile aqueous solution is adorned with a neutral pH (around 6.0) and bar code-enabled packaging. Specifically formulated for adult patients, Denosumab 60 mg/ml delivers heroic strength against osteoporosis, bone loss, and skeletal complications in those with bone metastases. Each single-use, odorless injection is easy to administer, preservative-free, and must be disposed of as per biomedical waste guidelines.

Versatile Clinical Application and Usage

The 60 ml Denosumab Solution Injection is widely employed by healthcare professionals, distributors, and suppliers across India for the treatment of adults with osteoporosis, bone loss, or skeletal-related conditions due to bone metastases. Used exclusively by medical practitioners, it is administered as a subcutaneous injection. Its innovative design supports clinical application and patient convenience, making it a trusted choice for export, trading, and distribution within the pharmaceutical sector.

List Price, Export Markets, and Swift Delivery

This Denosumab injection is available for export with competitive list pricing, catering to diverse global markets. Each unit is securely packaged, ensuring product integrity during transit. With a robust supply ability and reliable distribution channels, delivery times are optimized to meet client deadlines. The product ships from key Indian ports, with every consignment prepared for swift and efficient export according to the highest industry standards.

FAQ's of 60 Ml Denosumab Solution Injection:

Q: How should the 60 ml Denosumab Solution Injection be administered?

A: It should be administered as a subcutaneous injection by a trained healthcare professional, typically into the upper arm, thigh, or abdomen.

Q: What are the benefits of choosing this ready-to-use Denosumab solution?

A: The celebrated Denosumab solution offers convenient dosing with a prefilled syringe, ensuring accurate, single-use administration. It is preservative-free, sterile, and reduces preparation time.

Q: When is Denosumab solution indicated for use?

A: Denosumab is indicated for treating osteoporosis, preventing bone loss, and managing skeletal-related events in adult patients with bone metastases.